{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:33:00Z","timestamp":1788363180391,"version":"build-2803163510"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016950","name":"The Thompson Family Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Hatter Foundation"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/51\/34493"],"award-info":[{"award-number":["PG\/19\/51\/34493"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/PhD\/22\/29237"],"award-info":[{"award-number":["FS\/PhD\/22\/29237"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10798"],"award-info":[{"award-number":["PG\/21\/10798"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>In patients with coronary artery disease (CAD), morbidity and mortality from myocardial infarction remain high. Cardioprotective strategies such as remote ischaemic conditioning (RIC) are highly effective in animal models but have disappointed in large clinical trials. One explanation may be that ischaemia and reperfusion (I\/R) experiments are typically conducted in mice that lack CAD. Unlike most mouse models, double-mutant SR-BI\u0394CT\/\u0394CT;Ldlr KO mice do develop CAD when fed a high-fat diet (HFD). The aim of this study was therefore to use these mice to investigate cardioprotection in the setting of CAD. We hypothesized that RIC, which requires cell-surface receptor signalling, would be ineffective in these mice; but that UCL-TRO-1938, a phosphatidylinositol 3-kinase alpha (PI3K\u03b1) activator that bypasses cell-surface receptors, would be cardioprotective.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>After 6-week HFD, double-mutant mice, but not wild-type (WT) or Ldlr KO mice, developed CAD as determined by histology. Anaesthetized mice were subject to 30-min coronary ischaemia and 2-h reperfusion. In line with our hypothesis, RIC reduced infarct size in WT and Ldlr KO mice, but did not reduce infarct size in double-mutant mice subject to I\/R. We sought to understand the effects of CAD in double-mutant mouse hearts that might impair RIC, using RNA-sequencing (RNA-seq), immunostaining, and Western blot analysis. RNA-seq revealed significantly altered gene expression in double-mutant hearts compared with WT and Ldlr KO hearts, primarily in inflammatory pathways; in particular the interleukin-17 pathway. Coronary endothelial cells were activated, as shown by ICAM-1 expression in double-mutant but not Ldlr KO or WT. In contrast to RIC, treatment with UCL-TRO-1938 was cardioprotective in double-mutant mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The double-mutant SR-BI\u0394CT\/\u0394CT;Ldlr KO mouse strain may be a more clinically translatable mouse model of I\/R and cardioprotection. Furthermore, UCL-TRO-1938 is a promising cardioprotective drug as it remains effective in a mouse model with CAD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cvr\/cvaf111","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T16:56:59Z","timestamp":1749833819000},"page":"1722-1733","source":"Crossref","is-referenced-by-count":5,"title":["An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia\/reperfusion injury in mice with coronary atherosclerosis or insulin resistance"],"prefix":"10.1093","volume":"121","author":[{"given":"Pelin","family":"Golforoush","sequence":"first","affiliation":[{"name":"The Hatter Cardiovascular Institute, University College London , 67 Chenies Mews, London WC1E 6HX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"The Hatter Cardiovascular Institute, University College London , 67 Chenies Mews, London WC1E 6HX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"He","sequence":"additional","affiliation":[{"name":"The Hatter Cardiovascular Institute, University College London , 67 Chenies Mews, London WC1E 6HX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-9320","authenticated-orcid":false,"given":"Derek M","family":"Yellon","sequence":"additional","affiliation":[{"name":"The Hatter Cardiovascular Institute, University College London , 67 Chenies Mews, London WC1E 6HX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-4980","authenticated-orcid":false,"given":"Sean M","family":"Davidson","sequence":"additional","affiliation":[{"name":"The Hatter Cardiovascular Institute, University College London , 67 Chenies Mews, London WC1E 6HX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2025092907573289900_cvaf111-B1","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2025092907573289900_cvaf111-B2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia\u2013reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J Clin Invest"},{"key":"2025092907573289900_cvaf111-B3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ehjci\/jes271","article-title":"Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study","volume":"14","author":"Lonborg","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025092907573289900_cvaf111-B4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvu225","article-title":"ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies","volume":"104","author":"Lecour","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2025092907573289900_cvaf111-B5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00395-024-01094-6","article-title":"Inter-organ communication: pathways & targets to cardioprotection and neuroprotection. A report from the 12th hatter cardiovascular institute workshop","volume":"120","author":"Pearce","year":"2025","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-022-00947-2","article-title":"Remote ischaemic conditioning: defining critical criteria for success-report from the 11th hatter cardiovascular workshop","volume":"117","author":"Bell","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","article-title":"Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia\/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning","volume":"75","author":"Ferdinandy","year":"2023","journal-title":"Pharmacol Rev"},{"key":"2025092907573289900_cvaf111-B8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00395-020-00829-5","article-title":"Mouse models of atherosclerosis and their suitability for the study of myocardial infarction","volume":"115","author":"Golforoush","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00395-020-00830-y","article-title":"The importance of clinically relevant background therapy in cardioprotective studies","volume":"115","author":"He","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2013.01.005","article-title":"Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome","volume":"165","author":"Giraldez","year":"2013","journal-title":"Am Heart J"},{"key":"2025092907573289900_cvaf111-B11","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2337\/dc23-0871","article-title":"Cardiac insulin resistance in subjects with metabolic syndrome traits and early subclinical atherosclerosis","volume":"46","author":"Devesa","year":"2023","journal-title":"Diabetes Care"},{"key":"2025092907573289900_cvaf111-B12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.115.017534","article-title":"Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future","volume":"132","author":"Kolodgie","year":"2015","journal-title":"Circulation"},{"key":"2025092907573289900_cvaf111-B13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/bph.13704","article-title":"Effect of hypercholesterolaemia on myocardial function, ischaemia\u2013reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning","volume":"174","author":"Andreadou","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2025092907573289900_cvaf111-B14","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1111\/bph.14931","article-title":"Hyperlipidaemia and cardioprotection: animal models for translational studies","volume":"177","author":"Andreadou","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2025092907573289900_cvaf111-B15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.numecd.2017.08.005","article-title":"Saffron (Crocus sativus) intake provides nutritional preconditioning against myocardial ischemia\u2013reperfusion injury in wild type and ApoE((-\/-)) mice: involvement of Nrf2 activation","volume":"27","author":"Efentakis","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025092907573289900_cvaf111-B16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005344-200307000-00003","article-title":"Effects of angiotensin II Type 1 receptor blockade in ApoE-deficient mice with post-ischemic heart failure","volume":"42","author":"Pons","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025092907573289900_cvaf111-B17","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/01.ATV.19.11.2776","article-title":"Effects of hypercholesterolemia on myocardial ischemia\u2013reperfusion injury in LDL receptor-deficient mice","volume":"19","author":"Girod","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025092907573289900_cvaf111-B18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.ATV.0000105054.43931.f0","article-title":"Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators","volume":"24","author":"VanderLaan","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025092907573289900_cvaf111-B19","first-page":"288","article-title":"Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia\u2013reperfusion injury: a systematic review and meta-analysis","volume":"113","author":"Bromage","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2025092907573289900_cvaf111-B20","first-page":"1846","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"36","author":"Hausenloy","year":"2015","journal-title":"Eur Heart J"},{"key":"2025092907573289900_cvaf111-B21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCRESAHA.115.307523","article-title":"Murine \u201cmodel\u201d monotheism: an iconoclast at the altar of mouse","volume":"117","author":"Libby","year":"2015","journal-title":"Circ Res"},{"key":"2025092907573289900_cvaf111-B22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.123.067931","article-title":"Novel mouse model of myocardial infarction, plaque rupture, and stroke shows improved survival with myeloperoxidase inhibition","volume":"150","author":"Shamsuzzaman S, Deaton RA, Salamon A, Doviak H, Serbulea V, Milosek VM, Evans MA, Karnewar S, Saibaba S, Alencar GF, Shankman LS, Walsh K, Bekiranov S, Kocher O, Krieger M, Kull B, Persson M, Michaelsson E, Bergenhem N, Heydarkhan-Hagvall S, Owens GK.","year":"2024","journal-title":"Circulation"},{"key":"2025092907573289900_cvaf111-B23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cvr\/cvn114","article-title":"Remote ischaemic preconditioning: underlying mechanisms and clinical application","volume":"79","author":"Hausenloy","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2025092907573289900_cvaf111-B24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00395-014-0453-6","article-title":"Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th biennial hatter cardiovascular institute workshop","volume":"110","author":"Pickard","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection","volume":"12","author":"Hausenloy","year":"2007","journal-title":"Heart Fail Rev"},{"key":"2025092907573289900_cvaf111-B26","doi-asserted-by":"crossref","first-page":"H971","DOI":"10.1152\/ajpheart.00374.2004","article-title":"Ischemic preconditioning protects by activating prosurvival kinases at reperfusion","volume":"288","author":"Hausenloy","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025092907573289900_cvaf111-B27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00395-023-00992-5","article-title":"The RISK pathway leading to mitochondria and cardioprotection: how everything started","volume":"118","author":"Yellon","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jcmm.13394","article-title":"Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion","volume":"22","author":"Rossello","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2025092907573289900_cvaf111-B29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","article-title":"The role of PI3Kalpha isoform in cardioprotection","volume":"112","author":"Rossello","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-023-05972-2","article-title":"A small-molecule PI3Kalpha activator for cardioprotection and neuroregeneration","volume":"618","author":"Gong","year":"2023","journal-title":"Nature"},{"key":"2025092907573289900_cvaf111-B31","doi-asserted-by":"crossref","first-page":"H1392","DOI":"10.1152\/ajpheart.00463.2016","article-title":"Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.","volume":"311","author":"Pal","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025092907573289900_cvaf111-B32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.121.058740","article-title":"Glucose\u2013insulin\u2013potassium therapy for acute myocardial infarction: 50 years on and time for a relook","volume":"146","author":"Udelson","year":"2022","journal-title":"Circulation"},{"key":"2025092907573289900_cvaf111-B33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-0716-1307-8_22","article-title":"iDEP web application for RNA-seq data analysis","volume":"2284","author":"Ge","year":"2021","journal-title":"Methods Mol Biol"},{"key":"2025092907573289900_cvaf111-B34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"2025092907573289900_cvaf111-B35","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/ATVBAHA.114.304200","article-title":"The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, Type 1\/low-density lipoprotein receptor double knockout mice","volume":"34","author":"Fuller","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025092907573289900_cvaf111-B36","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.1990440","article-title":"Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis","volume":"251","author":"Cybulsky","year":"1991","journal-title":"Science"},{"key":"2025092907573289900_cvaf111-B37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1152\/physiolgenomics.00075.2001","article-title":"Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow","volume":"9","author":"Brooks","year":"2002","journal-title":"Physiol Genomics"},{"key":"2025092907573289900_cvaf111-B38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.yjmcc.2019.02.002","article-title":"Stromal cell-derived factor-1alpha signals via the endothelium to protect the heart against ischaemia\u2013reperfusion injury","volume":"128","author":"Bromage","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"2025092907573289900_cvaf111-B39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.phrs.2015.11.004","article-title":"Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS\/NO dependent mechanism","volume":"103","author":"Riquelme","year":"2016","journal-title":"Pharmacol Res"},{"key":"2025092907573289900_cvaf111-B40","doi-asserted-by":"crossref","first-page":"636134","DOI":"10.3389\/fphar.2021.636134","article-title":"Targeting the endothelium to achieve cardioprotection","volume":"12","author":"Herrera-Zelada","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025092907573289900_cvaf111-B41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s10020-020-00241-8","article-title":"PTEN inhibitor improves vascular remodeling and cardiac function after myocardial infarction through PI3k\/Akt\/VEGF signaling pathway","volume":"26","author":"Feng","year":"2020","journal-title":"Mol Med"},{"key":"2025092907573289900_cvaf111-B42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1254\/jphs.13247FP","article-title":"Cardioprotective effect of protocatechuic acid on myocardial ischemia\/reperfusion injury","volume":"125","author":"Tang","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"2025092907573289900_cvaf111-B43","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/cells11091553","article-title":"Insight into the role of the PI3K\/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart","volume":"11","author":"Walkowski","year":"2022","journal-title":"Cells"},{"key":"2025092907573289900_cvaf111-B44","doi-asserted-by":"crossref","first-page":"H437","DOI":"10.1152\/ajpheart.00384.2010","article-title":"eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex","volume":"299","author":"Talukder","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025092907573289900_cvaf111-B45","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCRESAHA.121.319150","article-title":"Where in the (lncRNA) world is CARMN? : safeguarding against vascular dysfunction","volume":"128","author":"Wang","year":"2021","journal-title":"Circ Res"},{"key":"2025092907573289900_cvaf111-B46","doi-asserted-by":"crossref","first-page":"e99697","DOI":"10.15252\/embj.201899697","article-title":"Deficiency in the nuclear long noncoding RNA Charme causes myogenic defects and heart remodeling in mice","volume":"37","author":"Ballarino","year":"2018","journal-title":"EMBO J"},{"key":"2025092907573289900_cvaf111-B47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nm.4479","article-title":"Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA","volume":"24","author":"Sallam","year":"2018","journal-title":"Nat Med"},{"key":"2025092907573289900_cvaf111-B48","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial","volume":"394","author":"Hausenloy","year":"2019","journal-title":"Lancet"},{"key":"2025092907573289900_cvaf111-B49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00395-021-00896-2","article-title":"Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2\/ERIC-PPCI CMR substudy","volume":"116","author":"Francis","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"2025092907573289900_cvaf111-B50","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","article-title":"Myocardial infarction\u2014from atherosclerosis to thrombosis","volume":"39","author":"Palasubramaniam","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025092907573289900_cvaf111-B51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM198010163031601","article-title":"Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction","volume":"303","author":"DeWood","year":"1980","journal-title":"N Engl J Med"},{"key":"2025092907573289900_cvaf111-B52","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1172\/JCI116060","article-title":"Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance","volume":"90","author":"Saad","year":"1992","journal-title":"J Clin Invest"},{"key":"2025092907573289900_cvaf111-B53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025092907573289900_cvaf111-B54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12933-023-02090-1","article-title":"Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis","volume":"22","author":"Iglesies-Grau","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2025092907573289900_cvaf111-B55","doi-asserted-by":"crossref","first-page":"5596590","DOI":"10.1155\/2021\/5596590","article-title":"Remote and anesthetic-induced myocardial preconditioning is preserved in atherosclerotic LDL receptor-\/- mice in vivo","volume":"2021","author":"Petermichl","year":"2021","journal-title":"Cardiovasc Ther"},{"key":"2025092907573289900_cvaf111-B56","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1159\/000366323","article-title":"Switching back to normal diet following high-fat diet feeding reduces cardiac vulnerability to ischaemia and reperfusion injury","volume":"34","author":"Littlejohns","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"2025092907573289900_cvaf111-B57","first-page":"5607349","article-title":"The correlation of dyslipidemia with the extent of coronary artery disease in the multiethnic study of atherosclerosis","volume":"2018","author":"Alamir","year":"2018","journal-title":"J Lipids"},{"key":"2025092907573289900_cvaf111-B58","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/eurheartj\/ehae250","article-title":"Vago-splenic signal transduction of cardioprotection in humans","volume":"45","author":"Lieder","year":"2024","journal-title":"Eur Heart J"},{"key":"2025092907573289900_cvaf111-B59","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.114.303822","article-title":"Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning","volume":"114","author":"Rassaf","year":"2014","journal-title":"Circ Res"},{"key":"2025092907573289900_cvaf111-B60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00424-016-1922-6","article-title":"Cardioprotection by remote ischemic conditioning and its signal transduction","volume":"469","author":"Kleinbongard","year":"2017","journal-title":"Pflugers Arch"},{"key":"2025092907573289900_cvaf111-B61","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cvr\/cvt140","article-title":"Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling","volume":"99","author":"Whittington","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2025092907573289900_cvaf111-B62","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1582-4934.2009.00796.x","article-title":"Preconditioning the diabetic human myocardium","volume":"14","author":"Sivaraman","year":"2010","journal-title":"J Cell Mol Med"},{"key":"2025092907573289900_cvaf111-B63","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"2025092907573289900_cvaf111-B64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/jrpp.jrpp_45_23","article-title":"Hypoglycemic agents and anesthetic techniques to ameliorate stress hyperglycemia in critically ill patients: a systematic review","volume":"12","author":"Rahimpour","year":"2023","journal-title":"J Res Pharm Pract"},{"key":"2025092907573289900_cvaf111-B65","doi-asserted-by":"crossref","first-page":"644189","DOI":"10.3389\/fcvm.2021.644189","article-title":"Type 2 diabetes and myocardial infarction: recent clinical evidence and perspective","volume":"8","author":"Cui","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025092907573289900_cvaf111-B66","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.107.697979","article-title":"Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection","volume":"117","author":"Kloner","year":"2008","journal-title":"Circulation"},{"key":"2025092907573289900_cvaf111-B67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity","volume":"103","author":"Dresner","year":"1999","journal-title":"J Clin Invest"},{"key":"2025092907573289900_cvaf111-B68","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nm0410-400","article-title":"Diacylglycerol-mediated insulin resistance","volume":"16","author":"Erion","year":"2010","journal-title":"Nat Med"},{"key":"2025092907573289900_cvaf111-B69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvx225","article-title":"IL-17 in atherosclerosis: the good and the bad","volume":"114","author":"Taleb","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2025092907573289900_cvaf111-B70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","article-title":"Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration","volume":"59","author":"Liao","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025092907573289900_cvaf111-B71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00395-021-00852-0","article-title":"Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response","volume":"116","author":"Pearce","year":"2021","journal-title":"Basic Res Cardiol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaf111\/63487438\/cvaf111.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/11\/1722\/63487438\/cvaf111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/11\/1722\/63487438\/cvaf111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:57:49Z","timestamp":1759147069000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/11\/1722\/8162312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":71,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2025,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaf111","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,6,13]]}}}